Hyperfine (HYPR) EPS (Diluted) Growth (1y) (2022 - 2026)
Hyperfine (HYPR) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 95.96% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -29.80% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 114.19% |
| 10 | Hyperfine | 94.82 Mn | 53.54 Mn | 1.98 Mn | 29.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.06% |
| Dec 31, 2025 | 49.63% |
| Sep 30, 2025 | 1.86% |
| Jun 30, 2025 | 16.19% |
| Mar 31, 2025 | 9.12% |
| Dec 31, 2024 | 4.23% |
| Sep 30, 2024 | 5.61% |
| Jun 30, 2024 | 5.64% |
| Mar 31, 2024 | 20.22% |
| Dec 31, 2023 | 19.18% |
| Sep 30, 2023 | 19.42% |
| Jun 30, 2023 | 54.62% |
| Mar 31, 2023 | 49.24% |
| Dec 31, 2022 | 97.38% |
| Sep 30, 2022 | 97.84% |
| Jun 30, 2022 | 96.26% |